BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:10 PM
 | 
Apr 10, 2008
 |  BC Extra  |  Financial News

Genentech beats Street EPS

Genentech (NYSE:DNA) posted 1Q08 non-GAAP diluted EPS of $0.84, beating by $0.02 the Street's estimate of $0.82 and up 14% from $0.74 in 1Q07. U.S. sales rose 8% to $2.2 billion from $2 billion in 1Q07. U.S. sales of Avastin bevacizumab for colorectal, breast and non-small cell...

Read the full 225 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >